Injectable Semaglutide

Semaglutide (the active ingredient in Ozempic® and Wegovy®) works as an agonist on only the GLP-1 (Glucagon-like Peptide-1) receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, and increased feelings of fullness, and it is used to improve blood sugar control and, in higher doses, for weight management.

Supports healthy blood sugar control

Once-weekly GLP-1 receptor support

Promotes feelings of fullness

View full details